A narrative literature review synthesizing preclinical evidence on nanoparticle radiosensitizers for proton therapy; raises mechanistic questions and identifies research gaps rather than reporting new empirical results or clinical outcomes.
Source
31 developments in the corpus
Latest
Everything in the corpus, newest first.
A narrative literature review synthesizing preclinical evidence on nanoparticle radiosensitizers for proton therapy; raises mechanistic questions and identifies research gaps rather than reporting new empirical results or clinical outcomes.
SEP 7, 2026 · JOURNAL ARTICLE
Cancers
A narrative review synthesizing early clinical trial data on an emerging technology without meta-analysis, formal quality assessment, or definitive efficacy endpoints; represents current state of evidence rather than practice-changing guidance.
SEP 7, 2026 · JOURNAL ARTICLE
Cancers
A narrative review that synthesizes existing findings on immune composition in chondrosarcoma but does not present new primary data, empirical results, or clinical outcomes to support specific interventions.
SEP 4, 2026 · JOURNAL ARTICLE
Cancers
Large retrospective cohort study with robust sample size documenting disparities in breast cancer presentation and treatment patterns between ethnic groups, with clear survival outcomes but relying on observational data and administrative records rather than experimental evidence.
SEP 4, 2026 · JOURNAL ARTICLE
Cancers
Retrospective real-world observational study without randomisation or concurrent control arms; provides outcome descriptors and treatment patterns but cannot establish comparative efficacy or causality for treatment strategies.
AUG 21, 2026 · JOURNAL ARTICLE
Cancers
This is a comprehensive review article synthesizing biological mechanisms and experimental technologies for miRNA modulation in breast cancer, without reporting primary clinical trial data or definitive therapeutic outcomes.
AUG 18, 2026 · JOURNAL ARTICLE
Cancers
A critical review examining methodological standardization, biological interpretation, and prognostic validation of pathologic response assessment in NSCLC, offering expert recommendations for harmonization and future strategies.
AUG 18, 2026 · JOURNAL ARTICLE
Cancers
A narrative review summarizing biological mechanisms, risk factors, and clinical approaches to VTE in hormone-sensitive cancers; provides expert synthesis rather than new empirical evidence.